Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov 6:13:1297152.
doi: 10.3389/fonc.2023.1297152. eCollection 2023.

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling

Affiliations
Editorial

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling

Michele Zanoni et al. Front Oncol. .
No abstract available

Keywords: cancer; metabolism; metastasis; purinergic signaling; resistance to therapy; stemness; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling

References

    1. Di Virgilio F, Adinolfi E. Extracellular purines, purinergic receptors and tumor growth. Oncogene (2017) 36(3):293–303. doi: 10.1038/onc.2016.206 - DOI - PMC - PubMed
    1. Di Virgilio F, Sarti AC, Falzoni S, De Marchi E, Adinolfi E. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer (2018) 18:601–18. doi: 10.1038/s41568-018-0037-0 - DOI - PubMed
    1. Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol (2022) 23:487–500. doi: 10.1038/S41590-022-01132-2 - DOI - PubMed
    1. Kepp O, Bezu L, Yamazaki T, Di Virgilio F, Smyth MJ, Kroemer G, et al. . ATP and cancer immunosurveillance. EMBO J (2021) 40(13):e108130. doi: 10.15252/embj.2021108130 - DOI - PMC - PubMed
    1. Amoroso F, Falzoni S, Adinolfi E, Ferrari D, Di Virgilio F. The P2X7 receptor is a key modulator of aerobic glycolysis. Cell Death Dis (2012) 3:e370. doi: 10.1038/cddis.2012.105 - DOI - PMC - PubMed

Publication types

LinkOut - more resources